{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:22:24Z","timestamp":1770744144496,"version":"3.49.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:sec>\n            <jats:title>Goals:<\/jats:title>\n            <jats:p>We retrospectively studied all seropositive Marsh 1 patients seen at 2 tertiary care hospitals in the last 15 years to determine their clinical, serological, and histologic outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Patients with positive celiac serologies and Marsh 1 histology represent an understudied subgroup of patients, and it is unclear whether they should be advised to adopt a gluten-free diet (GFD).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Study:<\/jats:title>\n            <jats:p>Subjects were identified based on positive celiac serologies and Marsh 1 histology while on a full-gluten diet. Clinical presentation and baseline laboratory data were noted. Clinical course, repeat serologies, and histology were determined.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Of 620 patients with positive celiac serologies and abnormal duodenal histology, we identified 36 (5.8%) with positive tissue transglutaminase and\/or antiendomysial antibodies and Marsh 1 lesions who had adequate follow-up. Abdominal pain was the commonest (47.2%) presenting symptom. Twenty-eight patients were advised to adopt GFD, whereas 8 were not. Among patients treated with GFD, 88.9% improved symptomatically and 95% normalized serology. In contrast, among patients who continued to consume gluten, 85.7% remained symptomatic and 80% had persistently positive serologies. Among the 8 patients on normal diet, 5 underwent repeat biopsy, and 4 of them had the same or worse histology, with 3 patients progressing to Marsh 3c. Among the 28 patients on GFD, 5 underwent repeat biopsy and all improved to normal histology.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Most patients with positive celiac serology and Marsh 1 lesions benefit from GFD and, if not treated, a majority will continue to be symptomatic and remain at risk of progressing to villous atrophy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mcg.0000000000000522","type":"journal-article","created":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T09:05:37Z","timestamp":1458637537000},"page":"619-623","source":"Crossref","is-referenced-by-count":6,"title":["Outcomes of Seropositive Patients With Marsh 1 Histology in Clinical Practice"],"prefix":"10.1097","volume":"50","author":[{"given":"Prashant","family":"Singh","sequence":"first","affiliation":[{"name":"Department of Medicine, Harvard Medical School"},{"name":"Gastrointestinal Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y.","family":"Lauwers","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Garber","sequence":"additional","affiliation":[{"name":"Department of Medicine, Harvard Medical School"},{"name":"Gastrointestinal Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230913","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(03)14027-5","article-title":"Coeliac disease","volume":"362","author":"Green","year":"2003","journal-title":"Lancet"},{"key":"R2-20230913","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/adc.65.8.909","article-title":"Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition","volume":"65","year":"1990","journal-title":"Arch Dis Child"},{"key":"R3-20230913","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0016-5085(92)91819-P","article-title":"Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (\u2018celiac sprue\u2019)","volume":"102","author":"Marsh","year":"1992","journal-title":"Gastroenterology"},{"key":"R4-20230913","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/00042737-199910000-00019","article-title":"The histopathology of coeliac disease: time for a standardized report scheme for pathologists","volume":"11","author":"Oberhuber","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R5-20230913","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/MPG.0b013e31821a23d0","article-title":"European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease","volume":"54","author":"Husby","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R6-20230913","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/ajg.2014.77","article-title":"Potential celiac children: 9-year follow-up on a gluten-containing diet","volume":"109","author":"Auricchio","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"R7-20230913","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3109\/00365521.2013.777470","article-title":"Prevalence and natural history of potential celiac disease in adult patients","volume":"48","author":"Biagi","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"R8-20230913","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1038\/ajg.2010.276","article-title":"Update on serologic testing in celiac disease","volume":"105","author":"Leffler","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R9-20230913","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cgh.2012.09.027","article-title":"Celiac disease with mild enteropathy is not mild disease","volume":"11","author":"Zanini","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R10-20230913","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/jcp.2003.013607","article-title":"Intraepithelial lymphocytes in the villous tip: do they indicate potential coeliac disease?","volume":"57","author":"Biagi","year":"2004","journal-title":"J Clin Pathol"},{"key":"R11-20230913","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/gut.34.2.150","article-title":"Clinical and pathological spectrum of coeliac disease\u2014active, silent, latent, potential","volume":"34","author":"Ferguson","year":"1993","journal-title":"Gut"},{"key":"R12-20230913","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3109\/00365521.2014.919019","article-title":"Predictive value of \u201cMarsh 1\u201d type histology in subjects with suspected cealic disease","volume":"49","author":"Tortora","year":"2014","journal-title":"Scand J Gastroenterol"},{"key":"R13-20230913","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jpeds.2010.02.070","article-title":"Celiac disease without villous atrophy in children: a prospective study","volume":"157","author":"Kurppa","year":"2010","journal-title":"J Pediatr"},{"key":"R14-20230913","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1053\/j.gastro.2008.11.040","article-title":"Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study","volume":"136","author":"Kurppa","year":"2009","journal-title":"Gastroenterology"},{"key":"R15-20230913","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cgh.2010.09.006","article-title":"Natural history of potential celiac disease in children","volume":"9","author":"Tosco","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R16-20230913","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.cgh.2007.03.019","article-title":"Comparison of the interobserver reproducibility with different histologic criteria used in celiac disease","volume":"5","author":"Corazza","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R17-20230913","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1572-0241.2001.03462.x","article-title":"Characteristics of adult celiac disease in the USA: results of a national survey","volume":"96","author":"Green","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R18-20230913","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1471-230X-11-118","article-title":"Delay to celiac disease diagnosis and its implications for health-related quality of life","volume":"11","author":"Norstrom","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"R19-20230913","doi-asserted-by":"crossref","first-page":"637187","DOI":"10.1155\/2012\/637187","article-title":"Atypical celiac disease: from recognizing to managing","volume":"2012","author":"Admou","year":"2012","journal-title":"Gastroenterol Res Pract"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00004836-201609000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T21:12:15Z","timestamp":1694639535000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004836-201609000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0000000000000522","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}